4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-060787
SVP, COO & CFO acquired 40,150 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2019-12-12 | Grant or award | +40,150 | 259,159 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2019-12-12 | Grant or award · Stock Option | +71,550 | 71,550 | D: show line 2 in the form | |||||
| Labrucherie Gil M SVP, COO & CFO | 2019-12-12 | Grant or award · Stock Option | +29,000 | 29,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…